Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (181-190 of 675) with videos related to

Pageof 68
Sort By:
Expert Opinion on Investigational Drugs|July 30, 2013
Statins and nonalcoholic fatty liver disease: a bright future?Vasilios G Athyros, Niki Katsiki, Asterios Karagiannis, et al.
Expert Opinion on Therapeutic Targets|June 17, 2008
Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?Konstantinos Tziomalos, Vasilios G Athyros, Asterios Karagiannis, et al.
Current Pharmaceutical Design|June 24, 2014
Hypolipidaemic drug treatment: yesterday is not gone yet, today is challenging and tomorrow is coming soon; let us combine them allVasilios G Athyros, Konstantinos Tziomalos, Asterios Karagiannis, et al.
Current Pharmaceutical Design|June 24, 2014
Combination of statin plus renin angiotensin system inhibition for the prevention or the treatment of atherosclerotic cardiovascular diseaseVasilios G Athyros, Niki Katsiki, Asterios Karagiannis, et al.
Atherosclerosis|April 19, 2008
Do we need to consider inflammatory markers when we treat atherosclerotic disease?Vasilios G Athyros, Anna I Kakafika, Asterios Karagiannis, et al.
Angiology|January 3, 2012
Local versus general anesthesia for carotid endarterectomy: issues beyond stroke, myocardial infarction, and death ratesKosmas I Paraskevas, Dimitri P Mikhailidis, Kyriakos Oikonomou, et al.
Current Pharmaceutical Design|April 1, 2011
Gender differences in the treatment of ischemic heart diseaseMarcin Barylski, Dimitri P Mikhailidis, Maciej Ciebiada, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a reviewAaron Tan, Christopher P Denton, Dimitri P Mikhailidis, et al.
Expert Opinion on Emerging Drugs|February 18, 2011
Emerging options in the treatment of dyslipidemias: a bright future?Matilda Florentin, Evangelos N Liberopoulos, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design|December 7, 2010
The estrogenic burden on vascular risk in male-to-female transsexualsEirini Lioudaki, Emmanuel S Ganotakis, Dimitri P Mikhailidis, et al.
Pageof 68

Showing results (181-190 of 675) with videos related to

Sort By:
Pageof 68
Expert Opinion on Investigational Drugs|July 30, 2013
Statins and nonalcoholic fatty liver disease: a bright future?Vasilios G Athyros, Niki Katsiki, Asterios Karagiannis, et al.
Expert Opinion on Therapeutic Targets|June 17, 2008
Established and emerging vascular risk factors and the development of aortic stenosis: an opportunity for prevention?Konstantinos Tziomalos, Vasilios G Athyros, Asterios Karagiannis, et al.
Current Pharmaceutical Design|June 24, 2014
Hypolipidaemic drug treatment: yesterday is not gone yet, today is challenging and tomorrow is coming soon; let us combine them allVasilios G Athyros, Konstantinos Tziomalos, Asterios Karagiannis, et al.
Current Pharmaceutical Design|June 24, 2014
Combination of statin plus renin angiotensin system inhibition for the prevention or the treatment of atherosclerotic cardiovascular diseaseVasilios G Athyros, Niki Katsiki, Asterios Karagiannis, et al.
Atherosclerosis|April 19, 2008
Do we need to consider inflammatory markers when we treat atherosclerotic disease?Vasilios G Athyros, Anna I Kakafika, Asterios Karagiannis, et al.
Angiology|January 3, 2012
Local versus general anesthesia for carotid endarterectomy: issues beyond stroke, myocardial infarction, and death ratesKosmas I Paraskevas, Dimitri P Mikhailidis, Kyriakos Oikonomou, et al.
Current Pharmaceutical Design|April 1, 2011
Gender differences in the treatment of ischemic heart diseaseMarcin Barylski, Dimitri P Mikhailidis, Maciej Ciebiada, et al.
Clinical and Experimental Rheumatology|May 19, 2011
Recent advances in the diagnosis and treatment of interstitial lung disease in systemic sclerosis (scleroderma): a reviewAaron Tan, Christopher P Denton, Dimitri P Mikhailidis, et al.
Expert Opinion on Emerging Drugs|February 18, 2011
Emerging options in the treatment of dyslipidemias: a bright future?Matilda Florentin, Evangelos N Liberopoulos, Dimitri P Mikhailidis, et al.
Current Pharmaceutical Design|December 7, 2010
The estrogenic burden on vascular risk in male-to-female transsexualsEirini Lioudaki, Emmanuel S Ganotakis, Dimitri P Mikhailidis, et al.
Pageof 68